1. Home
  2. HRMY vs IMKTA Comparison

HRMY vs IMKTA Comparison

Compare HRMY & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$33.41

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Ingles Markets Incorporated

IMKTA

Ingles Markets Incorporated

HOLD

Current Price

$87.23

Market Cap

1.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
IMKTA
Founded
2017
1963
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Food Chains
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
HRMY
IMKTA
Price
$33.41
$87.23
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$44.11
N/A
AVG Volume (30 Days)
718.4K
119.2K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
0.74%
EPS Growth
7.97
N/A
EPS
0.55
N/A
Revenue
$868,453,000.00
$5,334,032,609.00
Revenue This Year
$19.75
N/A
Revenue Next Year
$12.88
N/A
P/E Ratio
$60.29
$15.91
Revenue Growth
21.51
N/A
52 Week Low
$25.52
$59.27
52 Week High
$40.87
$95.62

Technical Indicators

Market Signals
Indicator
HRMY
IMKTA
Relative Strength Index (RSI) 54.50 43.99
Support Level $31.61 $86.31
Resistance Level $35.47 $89.76
Average True Range (ATR) 1.14 2.68
MACD 0.02 -0.36
Stochastic Oscillator 49.14 19.33

Price Performance

Historical Comparison
HRMY
IMKTA

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

Share on Social Networks: